Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 38 (2) , 215-222
- https://doi.org/10.1016/s0168-8278(02)00382-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Infant and adolescent hepatitis B immunization up to 1999: a global overviewVaccine, 2000
- Cost–benefit analysis of the Polish hepatitis B prevention programmeVaccine, 2000
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysisVaccine, 1997
- Rapid Approximation of Confidence Intervals for Markov Process Decision Models: Applications in Decision Support SystemsJournal of the American Medical Informatics Association, 1997
- An economic evaluation of universal vaccination against hepatitis B virusJournal of Infection, 1996
- Global programme for control of hepatitis B infectionVaccine, 1995
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective studyLiver International, 1989
- Survival and prognostic indicators in compensated and decompensated cirrhosisDigestive Diseases and Sciences, 1986